Logo

Register for

Werfen Autoimmunity Webinar Series

Utility of circulating calprotectin today and beyond Marvin J. Fritzler, Ph.D., M.D.
  • February 9, 2021
Additional utility of anti-tissue transglutaminase (tTG) testing to predict celiac disease Giulia Previtali, Ph.D.
  • March 17, 2021
Autoantibodies and clinical phenotype in systemic sclerosis Laura K. Hummers, M.D., ScM
  • April 21, 2021
APL panel approach testing in antiphospholipid syndrome (APS) Vittorio Pengo,  M.D.
  • May 19, 2021
Autoantibody profiles in the management of undifferentiated connective tissue disease (UCTD) Savino Sciascia, M.D., Ph.D.
  • June 16, 2021
Circulating calprotectin as an important tool in autoinflammatory disorders Maria Infantino, M.D.
  • July 21, 2021
Novel biomarkers in the management of liver autoimmunity Pietro Invernizzi, M.D.
  • August 18, 2021
Updates on Rheumatoid Arthritis Prediction and Prevention – a Vision for the Future & Emerging Biomarkers and Tools for Early Rheumatoid Arthritis Detection Kevin Deane, M.D., Ph.D. | Michael Mahler, Ph.D.
  • October 27, 2021
Autoimmune Gastritis from Pathogenesis to Laboratory Testing Maria Piera Panozzo Ph.D.
  • November 17, 2021
The cross-road between COVID-19 and autoimmunity: From the pathophysiology to the rebound of the immune system against the self. Pierluigi Meroni, M.D.
  • February 23, 2022
Autoantibodies to Ro52/TRIM21 and SSA/Ro60: A long and winding road Marvin J. Fritzler, Ph.D., M.D.
  • March 23, 2022
Myositis specific and associated antibodies: From laboratory detection to clinical management Boaz Palterer, M.D., PhD
  • April 27, 2022
Classification and management of adult inflammatory myopathies, role of serum diagnostics and evolving technologies Albert Selva O’Callaghan, M.D.
  • May 25, 2022
Celiac disease: Epidemiology, clinical features, diagnosis, and treatment. Benjamin Lebwohl, M.D., M.S.
  • June 22, 2022
Anti-dsDNA antibodies: Clinical and analytical issues Nicola Bizarro, M.D.
  • July 27, 2022